Hexarelin is a synthetic growth hormone secretagogue that has drawn steady interest from track athletes and strength coaches. The peptide binds to the ghrelin receptor and triggers a strong, short-lived pulse of growth hormone release. During a deliberate mass phase, the goal is to layer that pulse over heavy training and a calorie surplus. This is an editorial discussion of published research. It is not a treatment plan.
Most of the published work on hexarelin comes from the late 1990s and early 2000s. Those studies used doses far below what bodybuilders and sprinters often discuss today. A 1998 trial in normal young men found that a single subcutaneous dose of 2 mcg per kilogram produced a sharp GH peak within 30 minutes. That is roughly 160 to 200 mcg for an 80 to 100 kg athlete. The same trial noted that the GH response was larger than what was seen with similar doses of GHRP-6.
For a bulk, the practical question is not whether hexarelin works. The question is how to schedule it so the GH pulse lands when muscle is most receptive. Published research shows that GH release after hexarelin is blunted by high circulating free fatty acids. That means dosing right after a large mixed meal is less useful than dosing in a fasted window. Most experienced researchers settle on two or three daily injections, spaced four to six hours apart, with the first dose upon waking.
Why Hexarelin Fits a Bulk Better Than a Cut
Hexarelin has two properties that matter for lean mass accrual. First, it drives a rapid GH spike that can raise IGF-1 over repeated dosing. Second, it has direct effects on cardiac and skeletal muscle that are partly independent of GH. A 2002 animal study showed that hexarelin protected cardiac muscle from ischemic damage through a receptor pathway separate from the pituitary. That cardioprotective angle is relevant for athletes who push conditioning hard while gaining weight.
During a bulk, appetite is rarely the limiting factor. That removes one advantage of ghrelin mimetics like GHRP-6, which can make people noticeably hungry. Hexarelin is less likely to trigger a large appetite surge in most users. The literature on GHRP-6 suggests a stronger ghrelin-mediated hunger signal, which is useful in a cut but redundant when calories are already high. For this reason, hexarelin often replaces GHRP-6 in mass protocols.
Another point is desensitization. Early human data from 1999 indicated that the GH response to hexarelin declines after several weeks of continuous daily dosing. That decline is more pronounced than with CJC-1295, which is designed for a longer half-life and steadier GH output. A common workaround is to use hexarelin in short blocks of four to six weeks, then switch to a different secretagogue or take a break. The Hexarelin et entraînement en résistance : dosage et protocole article covers this cycling approach in more detail.
Dosing Ranges From the Research
Human studies have used hexarelin doses from 0.5 mcg per kilogram up to 3 mcg per kilogram. At the low end, a 90 kg athlete would inject roughly 45 to 60 mcg. At the high end, the same athlete would use 200 to 270 mcg per injection. Most anecdotal reports from bodybuilding communities cluster in the 100 to 200 mcg range, two or three times daily. That falls between the research doses and the higher doses seen in some underground protocols.
One important variable is injection timing relative to training. A 2001 study in older adults found that hexarelin increased GH and IGF-1 when given at night, but the effect on muscle strength was modest. That suggests hexarelin alone is not a strong anabolic agent without resistance training. When combined with heavy lifting, the GH pulse may amplify the normal post-training rise in IGF-1. The Hexarelin vs CJC-1295 for Muscle Growth: Which Wins? piece compares the two peptides on this exact point.
For a bulk, a defensible research-based protocol is 100 to 150 mcg injected subcutaneously upon waking, again in the early afternoon, and optionally a third dose before bed. The pre-bed dose can interfere with natural GH release during slow-wave sleep, so some researchers skip it. Others add a small dose of 50 to 100 mcg immediately post-workout. The key is keeping total daily exposure under roughly 400 to 500 mcg to limit desensitization.
Stacking Hexarelin With CJC-1295 and IGF-1 LR3
Hexarelin and CJC-1295 work through different mechanisms. Hexarelin is a ghrelin receptor agonist that causes a fast GH spike. CJC-1295 is a long-acting GHRH analog that raises the baseline GH trough. Published research on GHRH analogs shows a more sustained, lower-amplitude GH elevation. Combining the two can produce a pattern closer to youthful pulsatile secretion. A common research stack is 100 mcg of hexarelin plus 100 mcg of CJC-1295 (or modified GRF 1-29) twice daily.
IGF-1 LR3 is a different tool entirely. It bypasses the pituitary and acts directly on muscle and connective tissue. During a bulk, some researchers add 20 to 40 mcg of IGF-1 LR3 post-workout on training days only. The concern is that IGF-1 LR3 can suppress endogenous GH release through negative feedback. That would blunt the effect of hexarelin. A more conservative approach is to use IGF-1 LR3 on a separate schedule, such as every other day, or to reserve it for a later phase of the bulk when hexarelin sensitivity has declined.
BPC-157 is not a growth hormone peptide. It is a gastric peptide with reported effects on tendon and ligament healing. It does not directly increase lean mass. However, during a heavy bulk, joint and connective tissue stress rises. Some track athletes include BPC-157 at 250 to 500 mcg daily to support recovery from high-volume sprinting and lifting. That is a supportive role, not a mass-building one.
Practical Considerations for a Bulk Protocol
Hexarelin is typically supplied as a lyophilized powder that must be reconstituted with bacteriostatic water. A 5 mg vial reconstituted with 2 mL of water yields a concentration of 2500 mcg per mL. A 100 mcg dose is then 4 units on a standard U-100 insulin syringe. Accuracy matters because the dose-response curve is steep. A 2019 review of ghrelin receptor agonists noted that small changes in dose can produce large differences in GH output.
Injection site reactions are uncommon but possible. Rotating sites across the abdomen, thighs, and upper arms reduces local irritation. Hexarelin can also cause a transient drop in blood pressure or a brief facial flush. Those effects are usually mild and resolve within minutes. Athletes with a history of low blood pressure should start at the lower end of the dosing range.
Diet during a hexarelin bulk should be structured around the injection schedule. Because GH release is suppressed by high free fatty acids, it is best to avoid large fat-containing meals within 60 to 90 minutes before or after a dose. A moderate protein and carbohydrate meal is less likely to blunt the response. Some researchers keep the first dose fasted and then eat breakfast 30 to 45 minutes later.
Sleep is another variable. GH secretion is naturally highest during the first few hours of deep sleep. A late-night hexarelin dose can either add to that surge or disrupt it, depending on individual response. The 2022 review of growth hormone secretagogues in athletic populations noted that sleep quality is a major confounder in studies of GH peptides. If sleep quality drops after adding a pre-bed dose, that dose is probably doing more harm than good.
Monitoring and Adjusting the Protocol
Lean mass gains on a bulk are best tracked with a combination of scale weight, skinfold measurements, and performance in the gym. A reasonable target during a hexarelin research cycle is an increase of 0.25 to 0.5 kg per week, with the majority coming from lean tissue. If weight gain is faster, the surplus is likely too large and fat gain will follow. Hexarelin does not prevent fat gain; it only shifts the hormonal environment toward muscle protein synthesis.
Blood work can confirm whether the peptide is doing what the literature suggests. A serum IGF-1 test before starting and again after four weeks can show whether the protocol is raising systemic IGF-1. A rise of something like 30 to 50% is a typical response in published studies. A smaller rise may indicate desensitization or poor injection technique. A larger rise may warrant a dose reduction.
Prolactin and cortisol can also rise with chronic ghrelin receptor activation. Those changes are usually small and within normal limits at research doses. However, athletes who notice water retention, mood changes, or sleep disruption should consider a lower dose or a shorter cycle. The goal is to support training, not to create a new set of side effects.
Common questions
What is the best hexarelin dose for building muscle?
Published human research used doses from 0.5 to 3 mcg per kilogram. For a 90 kg athlete, that is roughly 45 to 270 mcg per injection. Most bulk protocols use 100 to 150 mcg two or three times daily. Total daily exposure above 400 to 500 mcg increases desensitization risk without a proportional gain in lean mass.
How long should a hexarelin bulk cycle last?
Most research and anecdotal reports point to four to six weeks as the useful window. After that, the GH response declines noticeably. A common pattern is four weeks on, two weeks off, or switching to a different secretagogue like CJC-1295 for a month. Longer continuous use is not supported by the desensitization data.
Can hexarelin be stacked with MK-677?
MK-677 is an oral ghrelin receptor agonist with a 24-hour half-life. It produces a sustained, low-level GH elevation. Stacking it with hexarelin would mean two drugs hitting the same receptor. That is likely to accelerate desensitization. Most researchers choose one or the other, not both at the same time.
Does hexarelin cause water retention?
Some users report mild water retention, especially at higher doses. This is thought to be related to increased aldosterone or direct renal effects of GH. The effect is usually less pronounced than with long-acting GHRH analogs. Reducing sodium intake and keeping the dose under 150 mcg per injection often resolves it.
Is hexarelin better than GHRP-6 for a bulk?
For most people, yes. GHRP-6 tends to increase hunger, which is not needed during a bulk. Hexarelin produces a stronger GH pulse per microgram and has additional cardioprotective effects. The main downside is faster desensitization, which is manageable with short cycles.